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A mammalian Wnt5a–Ror2–Vangl2 axis
controls the cytoskeleton and confers
cellular properties required for
alveologenesis
Kuan Zhang, Erica Yao, Chuwen Lin, Yu-Ting Chou, Julia Wong, Jianying Li,
Paul J Wolters†, Pao-Tien Chuang*
Cardiovascular Research Institute, University of California, San Francisco, San
Francisco, United States
Abstract Alveolar formation increases the surface area for gas-exchange and is key to the
physiological function of the lung. Alveolar epithelial cells, myofibroblasts and endothelial cells
undergo coordinated morphogenesis to generate epithelial folds (secondary septa) to form alveoli.
A mechanistic understanding of alveologenesis remains incomplete. We found that the planar cell
polarity (PCP) pathway is required in alveolar epithelial cells and myofibroblasts for alveologenesis
in mammals. Our studies uncovered a Wnt5a–Ror2–Vangl2 cascade that endows cellular properties
and novel mechanisms of alveologenesis. This includes PDGF secretion from alveolar type I and
type II cells, cell shape changes of type I cells and migration of myofibroblasts. All these cellular
properties are conferred by changes in the cytoskeleton and represent a new facet of PCP
function. These results extend our current model of PCP signaling from polarizing a field of
epithelial cells to conferring new properties at subcellular levels to regulate collective cell behavior.
Introduction
Gas exchange, the essential function of the lung, depends on the production of a sufficient number
of functional alveoli to provide surface area for gas exchange (Burri, 2006; Whitsett and Weaver,
2015; Chao et al., 2016). Elucidating the molecular mechanisms by which alveoli are formed
remains a major unresolved question. Lung branching morphogenesis is followed by the construction
of primary saccules at the distal end of the branching lung tree. The smooth wall of the primary sac-
cules is further modified by the generation of secondary crests or septa, which divide the saccules
into alveoli. As a result, the surface area of gas exchange is greatly increased to meet the high
demand of oxygen consumption in terrestrial, warm-blooded animals. Uncovering the molecular
basis of alveolar development will also provide insight into diseases that affect the alveoli. For
instance, bronchopulmonary dysplasia (BPD), in which maturation of alveoli fails to occur
(Silva et al., 2015), is prevalent in premature babies. Moreover, insults to the lung in adult life such
as infectious diseases or chronic obstructive pulmonary disease (COPD) can lead to destruction of
alveoli and respiratory failure (Patel et al., 2019). A mechanistic understanding of alveolar formation
will offer new therapies to regenerate alveolar surface area and treat diseases caused by loss of
alveoli (Rodrı´guez-Castillo et al., 2018).
The most important step in alveolar development is the formation of epithelial folds (secondary
septa) within the saccules, in which thin and flat alveolar type I (AT1) cells cover a core of myofibro-
blasts, connective tissue and capillaries (Branchfield et al., 2016). Compared to AT1 cells, alveolar
type II (AT2) cells contribute to a much smaller surface area for gas exchange but they play a central
role in lung expansion after birth by secreting pulmonary surfactants. During the first 2–3 days of
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postnatal life, the smooth wall (the primary septa) of saccules in wild-type mouse lungs is modified
by epithelial folding, which is termed rudimentary secondary crests or septa, to increase the surface
area for gas exchange. Secondary septa consist of alveolar type I cells that cover a core of myofibro-
blasts, connective tissue and capillaries (Chao et al., 2016). Elongation of secondary septa is associ-
ated with deposition of elastin by myofibroblasts and maturation of capillaries. At around postnatal
day 5, many of the primary saccules have been subdivided into alveoli by secondary septation
although this process will continue for another 25 days and beyond. Secondary septa formation
greatly increases the surface area for gas exchange in mammals and is the most critical event during
alveolar formation.
The current model posits that interstitial fibroblasts respond to platelet-derived growth factor
(PDGF) signaling and migrate to the prospective secondary septa to form alveolar myofibroblasts
(Chao et al., 2016), which express smooth muscle actin (SMA). It is postulated that myofibroblast
migration and elastin deposition by myofibroblasts provide the driving force for secondary septa
elongation. However, the molecular mechanisms that control cell migration remain poorly under-
stood. Similarly, the molecular processes that mediate interactions between alveolar epithelial cells
and prospective myofibroblasts during secondary septa formation are unknown. Importantly,
whether alveolar epithelial cells also play an active role in promoting alveologenesis has not been
determined. New insight into these key issues is pivotal to our mechanistic understanding of alveolar
formation.
We reasoned that signaling pathways that control the actomyosin cytoskeleton likely play a crucial
role in cell migration and interaction during secondary septa formation. The planar cell polarity
(PCP; also known as tissue polarity) pathway (Torban et al., 2012; Campanale et al., 2017;
Davey and Moens, 2017; Butler and Wallingford, 2017; Gray et al., 2011; Humphries and Mlod-
zik, 2018; Sokol, 2015; Zallen, 2007; Blair and McNeill, 2018; Peng and Axelrod, 2012) has been
shown to regulate the actomyosin cytoskeleton. In this study, we employed PCP signaling as a tool
to reveal the molecular basis of secondary septation and alveolar formation in mice. PCP (a non-
canonical Wnt pathway) is a fundamental, conserved mechanism for polarizing a field of cells within
the plane of an epithelial cell sheet and is essential in many tissues. PCP signaling is initiated by the
eLife digest The lungs enable the exchange of gases between inhaled air and the bloodstream.
This exchange happens in structures called alveoli, which have a large surface area that aids in
efficient gas exchange. Shortly after birth in mice, or during the last few months before birth in
humans, alveoli develop folds called secondary septa that increase their surface area and improve
the efficiency of gas exchange.
Several types of cells work together to form secondary septa. Surface cells called epithelia and
underlying “myofibroblast” cells and small blood vessels must both communicate and move
together to build the septa. The processes that control the formation of septa have not been fully
studied. In other cases, a cell signaling pathway known as the planar cell polarity (PCP) pathway has
been shown to help coordinate cell movements. The PCP pathway works by changing the
cytoskeleton of cells, which is the series of protein fibers that give cells their shape and structure and
the ability to move.
Zhang et al. have now studied septa in mouse lungs and revealed how three genes – Wnt5a, Ror2
and Vangl2 – in the PCP pathway control this process. This pathway oversees changes to the
cytoskeleton in both epithelial cells and myofibroblasts, helping the cells to change shape and move
together to form septa. Unusually, the PCP pathway has different effects in different cells, rather
than affecting all cells similarly. This is partly due to so-called PDGF signals from the epithelial cells
that help to guide the growth and movement of myofibroblasts. This process is helped by the
epithelial cells changing their shape to accommodate myofibroblasts during septa formation.
Further analysis also showed reduced PCP signaling in patients with chronic obstructive
pulmonary disease, also known as COPD. This could be a factor in the extensive lung damage seen
in these patients. These findings help to explain a key lung development process and may provide
new insights to understand lung diseases such as COPD.
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binding of Wnt ligands to the Frizzled (Fz) receptors (Wang et al., 2016). The signal is relayed by a
set of core PCP components that include cytoplasmic and membrane proteins. The outcome of PCP
signaling is an altered actomyosin cytoskeleton that is local and is associated with polarized cellular
function in a field of cells. The role of PCP components in lung development has been described
(Yates et al., 2010; Poobalasingam et al., 2017), but its molecular mechanisms are unknown. Other
well-characterized systems that require PCP include convergent extension in neural tube closure,
hair cell orientation in the cochlea of the inner ear, hair follicle orientation, and motile cilia position-
ing in the trachea. It is somewhat surprising that, in each system, the molecular mechanisms that
mediate PCP’s effects on cellular behavior are largely underexplored.
Our work described in this report has discovered a new mechanism of PCP signaling in which a
Wnt5a–Ror2–Vangl2 axis controls tissue patterning through regulating cellular properties and not tis-
sue polarity. Specifically, PCP signaling controls PDGF ligand secretion from alveolar type I and type
II cells, instructs cell shape change of alveolar type I cells, and regulates myofibroblast migration. All
of these are mediated though the actomyosin cytoskeleton. These novel insights significantly extend
our current understanding of alveolar formation and PCP signaling in tissue patterning. They not
only provide a new conceptual framework for understanding how the alveolus is generated during
development but also have a major impact on advancing disease mechanisms caused by alveolar
malformation or destruction.
Results
Inactivation of Vangl2 in the distal lung epithelium disrupts alveolar
formation
To understand how PCP pathway components control alveolar formation, we eliminated PCP signal-
ing in the distal lung epithelium by generating Vangl2f/f; Sox9Cre/+ mice. A floxed (f) allele of Vangl2
(Vangl2f) (Song et al., 2010) was converted into a null allele through strong expression of Cre from
the Sox9 locus (Sox9-Cre) (Akiyama et al., 2005) in the SOX9+ distal lung epithelium. During cana-
licular (16.5–17.5 days post coitus (dpc)) and saccular development (17.5 dpc–postnatal (P) day 4),
following the completion of branching morphogenesis, airspace at the terminal bronchioles is subdi-
vided to form saccules (Schittny, 2017). Lined by alveolar type I and type II cells, saccules function
as the primitive gas-exchange unit. As expected, VANGL2 protein was barely detectable in the distal
epithelium of Vangl2f/f; Sox9Cre/+ lungs by 18.5 dpc (shortly before birth), while VANGL2 expression
in the lung mesenchyme and elsewhere was unaffected (Figure 1—figure supplements 1, 2 and
3). Loss of Vangl2 abolishes PCP signaling since Vangl2 encodes a four-pass transmembrane protein
and is an essential component of mammalian PCP signaling (Bailly et al., 2018).
Vangl2f/f; Sox9Cre/+ animals were born alive and cannot be distinguished from their wild-type lit-
termates by their outer appearance or activity at birth (Figure 1—figure supplement 3). However,
at postnatal day 2, Vangl2f/f; Sox9Cre/+ mice can be identified by their slightly diminished body size.
The reduced size and activity in these mutants became more pronounced as postnatal development
proceeded. Mortality was observed in Vangl2f/f; Sox9Cre/+ mice at various time points postnatally,
especially between postnatal day 3 and 7 (mostly after day 4/5). Interestingly, a small number of
Vangl2f/f; Sox9Cre/+ mice survived beyond postnatal day 7. Vangl2-deficient lungs consisted of
enlarged saccules (Figure 1A) and failed to generate alveoli (Figure 1B). These results establish an
essential role of Vangl2 in alveolar formation (traditionally defined as P5-25 in mice) during lung
development.
Of note, the mammalian genome contains two homologs (Vangl1 and Vangl2) of fly Van Gogh
(Van)/strabismus. Vangl1-deficient mice that are homozygous for a gene-trapped null allele of Vangl1
(Vangl1gt) (Torban et al., 2008) are fully viable without apparent lung phenotypes and reproduce
with normal litter size. This suggests that Vangl1 plays a minor role in alveolar formation and loss of
Vangl1 is compensated by Vangl2 in alveologenesis. Of note, we failed to recover live Vangl1gt/gt;
Vangl2f/f; Sox9Cre/+ mice postnatally. Hence, our study on alveologenesis has focused on Vangl2.
Surprisingly, the widely used ShhCre (Harfe et al., 2004), which drives Cre expression along the
entire developing lung epithelium, failed to effectively eliminate VANGL2 (Figure 1—figure supple-
ment 4). Vangl1gt/gt; Vangl2f/f; ShhCre/+ mice were fully viable and fertile without apparent pheno-
types (Figure 1—figure supplement 4). In the literature, a hypomorphic (reduced function) allele of
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Figure 1. Vangl2 is required in both the lung epithelium and mesenchyme for alveolar formation. (A) Surface view
of dissected lungs from wild-type and Vangl2f/f; Sox9Cre/+ mice at different postnatal (P) stages as
indicated. Enlarged saccules were discerned in Vangl2f/f; Sox9Cre/+ lungs at P3 and their size increased significantly
as postnatal lung development proceeded. (B) Hematoxylin and eosin-stained lung sections of wild-type and
Vangl2f/f; Sox9Cre/+ mice at different postnatal stages. Histological analysis confirmed the presence of enlarged
Figure 1 continued on next page
Zhang et al. eLife 2020;9:e53688. DOI: https://doi.org/10.7554/eLife.53688 4 of 30
Research article Developmental Biology
Vangl2, Vangl2Lp (loop tail) (Murdoch et al., 2001), has been reported in several studies. Homozy-
gous Vangl2Lp/Lp mice die in utero due to neural tube defects while heterozygous Vangl2Lp/+ mice
display mild alveolar defects in adults but minimal alveolar phenotypes at postnatal day 7
(Poobalasingam et al., 2017). Thus, Vangl2Lp/+ mice are unsuitable for studying the molecular
mechanisms of alveolar formation. This would require complete removal of Vangl2 function in a
select compartment (e.g., the lung epithelium, mesenchyme or others) through conditional inactiva-
tion of Vangl2f using various mouse Cre lines. Our approach thus enables us to reveal how PCP sig-
naling regulates alveolar development.
To determine the cause of neonatal lethality in Vangl2f/f; Sox9Cre/+ mice, we examined lungs from
control and Vangl2f/f; Sox9Cre/+ mice at different time points postnatally. We noticed that the pri-
mary septa in control lungs became visibly thinner during the first three days of postnatal life likely
due to flattening of AT1 cells (Figure 1—figure supplement 5). The thickness of the primary septa
subsequently increased, presumably reflecting cell proliferation and structural changes in the mesen-
chyme and folding of AT1 cells (Figure 1—figure supplement 5), which is correlated with the pro-
gression of alveolar development (Yang et al., 2016). No obvious difference in the gross
morphology of the lungs was noticed between control and Vangl2f/f; Sox9Cre/+ mice prior to postna-
tal day 3 (Figure 1A). Histological analysis of control and Vangl2f/f; Sox9Cre/+ lungs showed no
apparent difference prior to postnatal day 3 (Figure 1B). Loss of Vangl2 mediated by Sox9-Cre thus
does not disrupt branching morphogenesis or saccule formation (Figure 1—figure supplement 3).
At postnatal day 3, enlarged saccules were discerned in Vangl2f/f; Sox9Cre/+ lungs in comparison
with controls under a dissecting microscope (Figure 1A). This finding was confirmed by morphologi-
cal analysis of dissected lungs using light microscopy (Figure 1B). Transmission electron microscopy
(TEM) of control and Vangl2f/f; Sox9Cre/+ lungs revealed lack of rudimentary secondary septa (arrows)
in the mutant lungs (Figure 1C). No apparent defects in other organs were found in Vangl2f/f; Sox9-
Cre/+ mice (Figure 1—figure supplement 6). The primary septa in Vangl2f/f; Sox9Cre/+ lungs under-
went a similar thinning process in the first three days of postnatal life. However, the primary septa in
mutant lungs failed to engender subsequent modification and retained a relatively thin appearance
(Figure 1B). These results suggest that loss of PCP signaling in the distal lung cells has a profound
influence on the normal progression and development of the primary septa to generate secondary
septa. Only a very small number of primordial secondary septa could be detected in Vangl2f/f;
Figure 1 continued
saccules in Vangl2-deficient lungs starting at P3. Arrows point to rudimentary secondary septa. (C) Transmission
electron micrographs of lungs from wild-type and Vangl2f/f; Sox9Cre/+ mice at P3. Rudimentary secondary septa
(arrows), in which the alveolar type I (AT1) cells encased myofibroblasts and blood vessels, were seen in control
but not Vangl2-deficient lungs. (D) Measurement of the mean linear intercept (MLI) in wild-type and Vangl2f/f;
Sox9Cre/+ lungs (n = 3 for each group). The MLI was increased in Vangl2-deficient lungs, starting at P3. (E)
Hematoxylin and eosin-stained lung sections of wild-type and Vangl2f/f; PdgfraCre/+ mice at different postnatal
stages. Enlarged saccules were detected in Vangl2f/f; PdgfraCre/+ lungs at P3 and their size increased significantly
as postnatal lung development proceeded. (F) Surface view of dissected lungs from wild-type and Vangl2f/f;
PdgfraCre/+ mice at P5. Larger saccules were found in Vangl2 mutant lungs induced by PdgfraCre. (G) Measurement
of the MLI in wild-type and Vangl2f/f; PdgfraCre/+ lungs (n = 3 for each group). The MLI was increased in Vangl2-
deficient lungs, starting at P5. (H) Hematoxylin and eosin-stained lung sections of wild-type and Vangl2f/f;
Dermo1Cre/+ mice at P5. Larger saccules were found in Vangl2 mutant lungs induced by Dermo1Cre. (I)
Measurement of the MLI in wild-type and Vangl2f/f; Dermo1Cre/+ lungs (n = 3 for each group). The MLI was
increased in Vangl2-deficient lungs. All values are mean ± SEM. (*) p<0.05; (**) p<0.01; ns, not significant (unpaired
Student’s t-test).
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. VANGL2 is broadly expressed in both the lung epithelium and mesenchyme.
Figure supplement 2. VANGL2 is selectively removed in the distal lung epithelium by Sox9-Cre.
Figure supplement 3. Sox9-Cre is broadly expressed but Vangl2f/f; Sox9Cre/+ mice do not display defects in lung
branching or saccule formation.
Figure supplement 4. Shh-Cre fails to efficiently remove Vangl2 in the lung epithelium.
Figure supplement 5. A time course of the development of the alveolar septa.
Figure supplement 6. Histological analysis of tissues and organs in Vangl2f/f; Sox9Cre/+ mice.
Figure supplement 7. Loss of epithelial Vangl2 disrupts secondary septa and alveolar formation.
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Sox9Cre/+ lungs. As a result, Vangl2-deficient lungs contained enlarged saccules (Figure 1B, Fig-
ure 1—figure supplement 7) with an increased mean linear intercept (MLI, a measure of air space
size) (Figure 1D). Disruption of secondary septa formation in the absence of PCP signaling in the dis-
tal lung epithelium likely led to respiratory failure and neonatal lethality.
Inactivation of Vangl2 in interstitial fibroblasts/myofibroblasts disrupts
alveolar formation, resembling loss of epithelial Vangl2
Most studies on PCP signaling have focused on how this pathway controls collective cell behavior in
epithelial sheets. Whether PCP signaling functions in mesenchymal cells is underexplored. To deter-
mine if PCP signaling is required in the lung mesenchyme for alveolar formation, we generated
Vangl2f/f; Dermo1Cre/+ and Vangl2f/f; PdgfraCre/+ mice. Dermo1 (Twist2) is broadly expressed in mes-
enchymal cells while Pdgfra, which encodes a receptor for the platelet-derived growth factor A
(PDGFA), is expressed in interstitial fibroblasts and induces smooth muscle actin (SMA) expression, a
hallmark of myofibroblasts. Thus, Cre expression from the Dermo1 locus (Dermo1Cre) (Yu et al.,
2003) would eliminate Vangl2 in most mesenchymal cells whereas Cre expression from the Pdgfra
locus (PdgfraCre) (Roesch et al., 2008) would inactivate Vangl2 in interstitial fibroblasts/myofibro-
blasts and disrupt PCP signaling.
We found that Vangl2f/f; Dermo1Cre/+ and Vangl2f/f; PdgfraCre/+ mice displayed lung phenotypes
(Figure 1E, F, G, H and I) resembling those in Vangl2f/f; Sox9Cre/+ mice. Secondary septa failed to
form in Vangl2f/f; Dermo1Cre/+ or Vangl2f/f; PdgfraCre/+ mice, saccules were enlarged with an
increased mean linear intercept, and many of the mutants failed to survive beyond postnatal day 7
(Figure 1E, F, G, H and I). We noticed that more Vangl2f/f; PdgfraCre/+ survivors with less severe
alveolar defects were observed than Vangl2f/f; Sox9Cre/+ survivors. This could be due to differential
Cre activity or differential contributions of epithelial and mesenchymal PCP signaling to alveolar for-
mation. Loss of one copy of Vangl1 did not exacerbate the lung phenotypes in Vangl2f/f; PdgfraCre/+
mice, highlighting the major role of Vangl2 in interstitial fibroblasts/myofibroblasts during alveolar
formation. We conclude that PCP signaling operates in both the lung epithelium and mesenchyme
and each process is essential for secondary septa formation by controlling distinct aspects of
alveologenesis.
Alveolar defects in mice carrying Ror2-deficient lung epithelium or
interstitial fibroblasts/myofibroblasts recapitulate phenotypes caused
by Vangl2 loss in the corresponding compartment
To reveal the signaling cascade that controls Vangl2 function and subsequently alveolar formation,
we tested the role of Ror2 (receptor tyrosine kinase-like orphan receptor 2), which has been impli-
cated in PCP signaling in other tissues (Ho et al., 2012). To this end, we generated Ror2f/f; Sox9Cre/+
mice and anticipated that a floxed allele of Ror2 (Ror2f) (Ho et al., 2012) would be converted to a
null allele in the distal lung epithelium by Sox9-Cre. If ROR2 is responsible for mediating VANGL2
activity, we predict that loss of Ror2 in the distal lung epithelium in Ror2f/f; Sox9Cre/+ mice would
result in alveolar defects similar to those in Vangl2f/f; Sox9Cre/+ mice. Indeed, Ror2f/f; Sox9Cre/+ mice
displayed neonatal lethality and their lungs failed to produce secondary septa (Figure 2A and B). A
detailed phenotypic analysis (Figure 2A and B) confirmed the similarity of lung phenotypes between
Ror2f/f; Sox9Cre/+ and Vangl2f/f; Sox9Cre/+ mice.
We also produced Ror2f/f; PdgfraCre/+ mice to remove Ror2 in lung interstitial fibroblasts/myofi-
broblasts. As predicted by our model of a Ror2–Vangl2 cascade, these mice died postnatally due to
alveolar defects (Figure 2C and D), resembling phenotypes observed in Vangl2f/f; PdgfraCre/+ mice.
Taken together, these studies established a key role of Ror2 in activating Vangl2 in either alveolar
epithelial cells or mesenchymal myofibroblasts. The downstream events mediated by Ror2–Vangl2
are critical for secondary septa formation and alveolar formation.
Mesenchymal Wnt5a signaling to lung epithelium and mesenchyme is
essential for alveolar development
A key question in further understanding how PCP signaling controls alveolar development is to
uncover the signals that trigger a Ror2–Vangl2 cascade. Several non-canonical Wnt ligands are
expressed in the lungs (Li et al., 2015) and are candidates for activating a Ror2–Vangl2 axis. We first
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Figure 2. Ror2 is required in both the lung epithelium and mesenchyme while Wnt5a is required in the lung mesenchyme for alveolar formation. (A)
Hematoxylin and eosin-stained lung sections of wild-type and Ror2f/f; Sox9Cre/+ mice at different postnatal (P) stages. Histological analysis revealed the
presence of enlarged saccules starting at P3 in Ror2-deficient lungs. (B) Surface view of dissected lungs from wild-type and Ror2f/f; Sox9Cre/+ mice at P5.
Larger saccules were found in Ror2 mutant lungs induced by Sox9Cre and the MLI was correspondingly increased in Ror2-deficient lungs. (C)
Hematoxylin and eosin-stained lung sections of wild-type and Ror2f/f; PdgfraCre/+ mice at P5. Histological analysis confirmed the presence of enlarged
saccules starting at P3 in Ror2-deficient lungs. (D) Surface view of dissected lungs from wild-type and Ror2f/f; PdgfraCre/+ mice at P5. Larger saccules
were found in Ror2 mutant lungs induced by PdgfraCre with an increased MLI. (E) Hematoxylin and eosin-stained lung sections of wild-type and Porcnf/f;
PdgfraCre/+ mice at P12. Larger saccules were found in Porcn mutant lungs induced by Pdgfra-Cre with an increased MLI. (F) Hematoxylin and eosin-
stained lung sections of wild-type and Wnt5af/f; Tbx4Cre/+ mice at P10. Larger saccules were found in Wnt5a mutant lungs induced by Tbx4-Cre with an
increased MLI. (G) Combined in situ hybridization (PLISH)/immunohistochemistry on lung sections of PdgfraH2BGFP/+ mice to examine Wnt5a expression.
Wnt5a mRNA was mainly detected in myofibroblasts (H2BGFP+) and not in the lung epithelium. (H) Schematic diagram of a Wnt5a–Ror2–Vangl2 axis
that functions in both the lung epithelium and mesenchyme to regulate alveologenesis. (I) Schematic diagram of the temporal sequence of fibroblast/
myofibroblast proliferation, differentiation and migration.
Figure 2 continued on next page
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manipulated the activity of Porcupine (Porcn) in the lung, which is required for the release of all
WNT proteins from Wnt-producing cells (Cadigan and Peifer, 2009; MacDonald et al., 2009). Con-
sistent with the involvement of Wnt signaling in alveolar development, treatment of neonatal mice
with Wnt-C59 (Proffitt et al., 2013) or LGK974 (WNT-974) (Liu et al., 2013), inhibitors of PORCU-
PINE, resulted in alveolar defects (Figure 2—figure supplement 1). Moreover, inactivation of Porcn
in the lung mesenchyme by creating Porcnf/f; Dermo1Cre/+ mice or in lung myofibroblasts by gener-
ating Porcnf/f; PdgfraCre/+ mice also led to alveolar defects (Figure 2—figure supplement 2,
Figure 2E). In this setting, a floxed allele of Porcn (Porcnf) (Liu et al., 2012) was removed by
Dermo1-Cre or Pdgfra-Cre. These results support the notion that Wnt signals in the lung mesen-
chyme initiate PCP signaling for alveolar development.
Among the Wnt ligands, WNT5A is a likely candidate in activating a Ror2–Vangl2 cascade in the
lung mesenchyme. Wnt5a transcripts were detected in fibroblasts and myofibroblasts (Figure 2—fig-
ure supplement 3) and a very small number of alveolar epithelial cells by single cell RNA-Seq analy-
sis of postnatal lungs (Guo et al., 2019). Moreover, Wnt5a-deficient lungs exhibit a shortened
trachea (Li et al., 2002; Kishimoto et al., 2018), consistent with defective PCP signaling. Whether
Wnt5a controls PCP signaling during alveolar development is unknown. We first performed PLISH
(proximity ligation in situ hybridization) (Nagendran et al., 2018) on lungs from PdgfraH2BGFP mice
(Hamilton et al., 2003) to examine the expression patterns of Wnt5a in postnatal lungs. Expression
of the H2B-GFP fusion protein in the nucleus of Pdgfra-expressing cells (PdgfraH2BGFP) unambigu-
ously marked myofibroblasts. We found that Wnt5a mRNA was mainly expressed in myofibroblasts
and barely any signal was detected in the lung epithelium (Figure 2G).
To test the role of Wnt5a in activating a Ror2–Vangl2 cascade, we initially utilized Sox9-Cre,
Pdgfra-Cre and Dermo1-Cre to convert a floxed allele of Wnt5a (Wnt5af) (Ryu et al., 2013) into a
null allele. Unfortunately, Wnt5af/f; Sox9Cre/+, Wnt5af/f; PdgfraCre/+ and Wnt5af/f; Dermo1Cre/+ mice
all died soon after birth due to craniofacial defects. The perinatal lethality prevented us from analyz-
ing alveolar defects in these animals. To circumvent this problem, we employed Tbx4-Cre
(Kumar et al., 2014) to inactivate Wnt5a selectively in the lung mesenchyme but not the mesen-
chyme of other tissues. Wnt5af/f; Tbx4Cre/+ mice were born alive but many displayed a smaller body
size at postnatal day 4 or 5. Phenotypic analysis of Wnt5af/f; Tbx4Cre/+ lungs revealed defective alve-
olar formation (Figure 2F) albeit the alveolar defects were not as pervasive as those caused by loss
of Ror2 or Vangl2. In other experimental settings, we have found that Tbx4-Cre is less efficient in
conditional gene inactivation in comparison to other Cre lines.
Taken together, our genetic studies have established a Wnt5a–Ror2–Vangl2 axis in controlling
alveolar formation (Figure 2H). In this process, mesenchymal Wnt5a triggers a Ror2/Vangl2–medi-
ated cascade in both lung epithelium and mesenchyme.
In many studies where PCP signaling controls the collective cell behavior of epithelial sheets, PCP
components display asymmetric distribution within individual epithelial cells. This is proposed to
underlie the coordination between epithelial cells through organizing the cytoskeleton along the
same axis among individual cells. We thus examined VANGL2 distribution in either lung epithelial
cells or mesenchymal myofibroblasts. To our surprise, we found no apparent asymmetric localization
of VANGL2 in alveolar type I cells, alveolar type II cells or myofibroblasts (Figure 2—figure supple-
ment 4). This led to our new model in which a Wnt5a–Ror2–Vangl2 axis controls cellular properties
of individual lung cells regardless of asymmetric activation of PCP components. We speculate that
this cascade sets in motion PDGF signaling from alveolar type I and type II cells, morphological
changes of alveolar type I cells and migration of myofibroblasts, all of which are required for alveolar
formation. We will test these hypotheses in subsequent sections.
Figure 2 continued
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Inhibition of PORCUPINE activity leads to alveolar defects.
Figure supplement 2. Elimination of mesenchymal Porcupine affects alveolar formation.
Figure supplement 3. Single-cell RNA-Seq reveals expression of Wnt5a in myofibroblasts.
Figure supplement 4. VANGL2 is not asymmetrically localized in lung epithelial and mesenchymal cells.
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Loss of epithelial Vangl2 leads to defective PDGF signal reception in
mesenchymal myofibroblasts
Lack of secondary septa in Vangl2f/f; Sox9Cre/+ mice was associated with thin primary septa. This
prompted us to investigate whether proliferation and function of myofibroblasts were affected in the
absence of epithelial PCP signaling in Vangl2f/f; Sox9Cre/+ lungs. In wild-type lungs, fibroblast prolif-
eration can be detected at P0; this is followed by SMA expression at P2/3 and subsequent migration
while proliferation continues (Figure 2I). Indeed, we found that interstitial fibroblasts that expressed
PDGFRA failed to proliferate as revealed by reduced EdU incorporation in Vangl2f/f; PdgfraH2BGFP/+;
Sox9Cre/+ mice in comparison with PdgfraH2BGFP/+ mice (controls) (Figure 3A, Figure 3—figure sup-
plement 1). Myofibroblasts were labeled by H2BGFP. Moreover, myofibroblasts (SMA+) in Vangl2f/f;
Sox9Cre/+ lungs failed to migrate to the prospective sites of secondary septa formation (Figure 3B).
Decreased myofibroblast proliferation first appeared at postnatal day 2 when PDGFRA+ interstitial
fibroblasts started to express SMA and became myofibroblasts. This suggests that expansion of
fibroblasts prior to SMA expression and migration was disrupted in the absence of epithelial Vangl2.
By postnatal day 3, the number of PDGFRA+ interstitial fibroblasts had vastly decreased in the
mutant lungs (Figure 3C). This was associated with a major reduction in SMA+ cells. Myofibroblasts
secrete elastin and collagen, which play an important role in promoting secondary septa formation.
As expected, both SMA and elastin production was significantly curtailed in Vangl2f/f; Sox9Cre/+
lungs (Figure 3D).
Given the reciprocal interaction between the lung epithelium and mesenchyme, we speculate
that aberrant myofibroblast development in Vangl2f/f; Sox9Cre/+ lungs stems from malfunction of the
lung epithelium. We first tested whether perturbation of pathways that signal from the lung epithe-
lium to the mesenchyme would have caused anomalous alveolar formation in Vangl2f/f; Sox9Cre/+
mice and found that PDGF signaling was disrupted in myofibroblasts in these animals. PDGFA is pro-
duced primarily in alveolar type I and type II cells and signals to Pdgfra-expressing fibroblasts/myofi-
broblasts (Chen and Krasnow, 2012; Gouveia et al., 2017) to regulate their proliferation and
migration. While loss of either Pdgfa (Bostro¨m et al., 1996; Lindahl et al., 1997) or Pdgfra
(Sun et al., 2000) can result in loss of secondary septa (Noskovicˇova´ et al., 2015), we found no dif-
ference in PDGFA ligand production between control and Vangl2f/f; Sox9Cre/+ lungs by both qPCR
analysis and in situ hybridization. This conclusion was substantiated by a PDGFA reporter mouse line
(Pdgfaex4COIN) (Andrae et al., 2014) that faithfully recapitulates the spatial and temporal expression
of Pdgfa since no reliable PDGFA antibody is available to detect endogenous PDGFA in tissues
(Gouveia et al., 2017; Andrae et al., 2014). In Pdgfaex4COIN/+; Sox2Cre/+ mice, Cre recombinase
was broadly expressed and activated b-galactosidase (lacZ) expression (from the Pdgfaex4COIN allele)
in Pdgfa-expressing cells, including AT1 (HOPX+) and AT2 (SPC+) cells (Figure 3E). LacZ expression
in Pdgfa-expressing epithelial cells is indicative of PDGFA levels. We found that PDGFA was
expressed more frequently in AT1 cells than AT2 cells and PDGFA expression levels were higher in
AT1 cells than AT2 cells (Figure 3E), consistent with single-cell RNA-Seq data (Wang et al., 2018).
We generated Vangl2f/f; Pdgfaex4COIN/+; Sox9Cre/+ to examine the effects of epithelial VANGL2 on
PDGFA expression. PDGFA displayed a similar pattern and intensity between control and Vangl2-
deficient lungs (Figure 3F), consistent with no reduction in Pdgfa transcript levels in the absence of
Vangl2 (Figure 3F). These results pointed to defective PDGF ligand trafficking, secretion or delivery
in Vangl2f/f; Sox9Cre/+ lungs after the PDGF ligand is made. It also predicts that PDGF fails to trans-
duce its signal to mesenchymal myofibroblasts of Vangl2f/f; Sox9Cre/+ lungs.
Consistent with our model, while the levels of PDGFRA in a single myofibroblast were unaffected
(Figure 3G), phosphorylation of PDGFRA in individual myofibroblasts upon PDGFA ligand binding
was significantly reduced in Vangl2f/f; Sox9Cre/+ lungs (Figure 3H, Figure 3—figure supplement 2).
In addition, activation of the downstream kinases, such as AKT (a serine-threonine kinase)
(Demoulin and Essaghir, 2014), was drastically diminished in Vangl2f/f; Sox9Cre/+ lungs in compari-
son with controls by immunostaining (Figure 3—figure supplement 3). Disrupted PDGF signal trans-
duction in myofibroblasts led to reduced proliferation and migration. These findings support our
model in which the PDGFA ligand produced in Vangl2-deficient alveolar epithelial cells fails to trans-
duce its signal to mesenchymal myofibroblasts.
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Figure 3. Vangl2 is required for PDGF ligand trafficking/release from PDGF-producing cells and subsequently PDGF signal reception. (A)
Immunostaining of lung sections collected from PdgfraH2BGFP/+ (control) and Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ mice injected with EdU at postnatal (P)
day 5. Lung epithelial cells were distinguished by NKX2.1 staining while myofibroblasts were marked by H2B-GFP from the Pdgfra locus (PdgfraH2BGFP).
The number of EdU+ cells was reduced in Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ lungs compared to controls. (B) Immunostaining of lung sections
collected from control and Vangl2f/f; Sox9Cre/+ mice at P5. Organization of the cytoskeleton and stress fibers was disrupted and SMA at the prospective
sites of secondary septation was sparse in Vangl2-deficient lungs. (C) Quantification of myofibroblast proliferation in PdgfraH2BGFP/+ (control) and
Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ lungs at P2 and P5. The rate of myofibroblast proliferation was calculated as the ratio of the number of EdU+
myofibroblasts (EdU+H2BGFP+) to the number of myofibroblasts (H2BGFP+). An apparent reduction in the percentage of proliferating myofibroblasts
was detected in Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ lungs compared to controls (n = 3 for each group) at P2 and P5. (D) qPCR analysis of Acta2 (SMA)
and Elastin in control and Vangl2f/f; Sox9Cre/+ lungs at P3. The mRNA levels of Acta2 and Elastin were significantly reduced in the absence of epithelial
Vangl2 induced by Sox9-Cre (n = 3 for each group). (E) Immunostaining of lung sections collected from Pdgfaex4COIN/+; Sox2Cre/+ mice at P2. b-
galactosidase (LacZ) was induced in PDGFA-producing cells by Sox2-Cre. LacZ-staining (blue) was followed by immunostaining against HOPX (marker
Figure 3 continued on next page
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Alveolar epithelial cells lacking VANGL2 fail to present the PDGF ligand
to mesenchymal myofibroblasts
Our results indicate that loss of PCP signaling in alveolar epithelial cells disrupts their ability to trans-
duce the PDGF signal to myofibroblasts in the mesenchyme. We envision that either the PDGF
ligand failed to reach the cell surface of alveolar type I/II cells or failed to be delivered to target cells.
To gain insight into this issue, we performed RNA-Seq analysis (Hrdlickova et al., 2017) of control
and Vangl2f/f; Sox9Cre/+ lungs collected at P2 and P5. Interestingly, pathways that regulate vesicular
transport were perturbed in the mutant lungs (details below), suggesting their role in PDGF secre-
tion. To explore this idea, we assayed intracellular trafficking and secretion of PDGFA in control and
Vangl1/2-deficient cells. Control and Vangl1/2-deficient cells were derived from control and
Vangl1gt/gt; Vangl2–/– embryos and subsequently lentivirally transduced with constructs that encode
a fusion protein of PDGFA and 3xFLAG or GFP. Using this assay, we determined the amount of
PDGFA-3xFLAG released from control and Vangl1/2-deficient cells. PDGFA-3xFLAG in the media
incubated with Vangl1/2-deficient cells was significantly reduced (Figure 3I). These findings are con-
sistent with a failure in vesicular transport and ligand release of PDGFA without Vangl1/2. Indeed,
we found that the intracellular levels of PDGFA-GFP were increased in Vangl1/2-deficient cells
(Figure 3J, Figure 3—figure supplement 4).
Consistent with our model in which the PDGF ligand fails to be released from alveolar epithelial
cells in the absence of Vangl1/2, inactivation of Vangl1/2 in alveolar type II cells (Surfactant protein C
[SP-C or SPC]+ encoded by Sftpc) led to alveolar defects. We generated Vangl1gt/gt; Vangl2f/f;
SftpcCreER/+ mice and administered tamoxifen to these animals at P2. Activation of CreER by tamoxi-
fen in SPC+ cells (Lin et al., 2012) induced Vangl2 removal. Analysis of lungs at P10 revealed areas
of defective alveolar development that was associated with loss of Vangl1/2 (Figure 3K, Figure 3—
Figure 3 continued
for AT1 cells) and SPC (marker for AT2 cells). LacZ-positive cells also expressed either HOPX or SPC. The number of AT1 or AT2 cells that harbored
either high or low PDGFA (LacZ) was counted. (F) LacZ-staining (blue) of lung sections collected from Pdgfaex4COIN/+; Sox9Cre/+ (control) and Vangl2f/f;
Pdgfaex4COIN/+; Sox9Cre/+ mice at P2. The slides were counterstained with eosin (red). No difference in the intensity of LacZ (+) cells in the lung was
found in these two mouse lines. The mRNA levels of Pdgfa in control and mutant lungs were determined by qPCR. (G) Immunostaining of lung sections
collected from control and Vangl2f/f; Sox9Cre/+ mice at P3. No difference in PDGFRA expression levels in individual myofibroblasts was noted between
control and Vangl2f/f; Sox9Cre/+ lungs. (H) Immunostaining of lung sections collected from control and Vangl2f/f; Sox9Cre/+ mice at P3. A significant
reduction in the levels of phosphorylated (p) PDGFRA in individual myofibroblasts was found in Vangl2f/f; Sox9Cre/+ lungs compared to controls. (I)
Western blot analysis of cell lysates and supernatants from control and Vangl1gt/gt; Vangl2–/– cells lentivirally transduced with PDGFA-expressing
constructs. The amount of PDGFA released into the media was significantly reduced in Vangl1gt/gt; Vangl2–/– cells compared to controls (n = 3 for each
group). GAPDH served as a loading control. We noticed that the amount of secreted proteins (normalized to the cell number) from Vangl1/2 mutant
cells was reduced compared to controls. This suggests a general defect in protein processing/secretion in the absence of Vangl1/2. In this case, it is
possible that other secreted ligands could also impact alveolar development. (J) Immunostaining of controls and Vangl1gt/gt; Vangl2–/– cells lentivirally
transduced with PDGFA-expressing constructs. Endoplasmic reticulum (ER) was marked by mEmerald-ER-5. (K) Hematoxylin and eosin-stained lung
sections of wild-type and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+ mice injected with tamoxifen and collected at P10. Enlarged saccules were found in
Vangl1gt/gt; Vangl2f/f; SftpcCreER/+ lungs in comparison with controls. (L) Immunostaining of controls and Vangl1gt/gt; Vangl2–/– cells. The Golgi stacks
were dispersed in Vangl1gt/gt; Vangl2–/– cells compared to controls. Golgi was marked by mEmerald-Golgi-7. (M) Transmission electron micrographs of
lungs from wild-type and Vangl2f/f; Sox9Cre/+ mice at P3. Cellular extension (arrow) from alveolar type II cells to myofibroblasts was observed in control
lungs but were absent in Vangl2f/f; Sox9Cre/+ lungs. (N) Schematic diagram of a positive feedback loop between WNT5A and PDGF to generate a pool
of fibroblasts/myofibroblasts for alveologenesis. All values are mean ± SEM. (*) p<0.05; (**) p<0.01; (***) p<0.001; ns, not significant (unpaired Student’s
t-test).
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Loss of epithelial Vangl2 leads to reduced myofibroblast proliferation.
Figure supplement 2. Removal of epithelial Vangl2 results in reduced levels of phosphorylated PDGFRA.
Figure supplement 3. PDGF signal reception is reduced in lungs deficient in Vangl1/2 signaling.
Figure supplement 4. Accumulation of PDGF ligand in the secretory pathway in the absence of VANGL1/2.
Figure supplement 5. Loss of Vangl1/2 in alveolar type II cells results in alveolar defects.
Figure supplement 6. Removal of mesenchymal Wnt5a results in reduced levels of phosphorylated PDGFRA.
Figure supplement 7. Mesenchymal Wnt signaling is required for fibroblast/myofibroblast proliferation but does not affect differentiation of alveolar
epithelial cells.
Figure supplement 8. PDGF signaling is required for preserving a pool of WNT5A-secreting myofibroblasts.
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figure supplement 5). This supports a critical role of Vangl1/2 in alveolar type II cells during
alveologenesis.
We also discovered that the structure of the Golgi apparatus was altered in Vangl1/2-deficient
cells. Compared to control cells in which the Golgi apparatus was properly polarized inside the cells,
the Golgi stacks were dispersed in Vangl1/2-deficient cells (Figure 3L). We speculate that loss of the
proper organization of the Golgi apparatus could contribute to disruption of the secretory pathways
including PDGF ligand secretion.
Alveolar type II cells make direct cell-cell contacts with myofibroblasts via cellular processes that
pass through the basement membrane (Figure 3M; Brody et al., 1982; Adamson and King, 1985).
Such cell-cell contacts could facilitate PDGF signaling as supported by recent studies in which most,
if not all, major signaling pathways are shown to require cell-cell contacts for ligand-receptor interac-
tions and signal transduction (Kornberg, 2017; Kornberg, 2019). In this scenario, ablation of PCP
signaling in alveolar epithelial cells would affect the actomyosin cytoskeleton, a common output of
PCP signaling, and consequently either the formation or function of cellular processes that are
required for transducing the PDGF signal. Interestingly, TEM studies revealed loss of cellular pro-
cesses from alveolar type II cells in Vangl2f/f; Sox9Cre/+ lungs, which were no longer in direct contact
with myofibroblasts (Figure 3M).
Taken together, our studies support a model in which alveolar type I and type II cells utilize a
Wnt5a–Ror2–Vangl2 cascade to control PDGF ligand trafficking and release and contribute to sec-
ondary septa formation. We surmise that these effects are mediated by the actomyosin
cytoskeleton.
WNT5A and PDGF forms a positive feedback loop to generate a pool
of fibroblasts/myofibroblasts required for alveologenesis
In our model, a Wnt5a–Ror2–Vangl2 cascade operates in both the epithelial and mesenchymal com-
partments. We investigated how these signaling events are coordinated during postnatal lung devel-
opment. We found that phosphorylation of PDGFRA in individual myofibroblasts upon PDGFA
ligand binding was reduced in Wnt5af/f; Tbx4Cre/+ lungs (Figure 3—figure supplement 6), while the
levels of PDGFRA were unaffected (Figure 3—figure supplement 6). Moreover, elimination of mes-
enchymal Wnt signaling (including WNT5A secretion from fibroblasts) prior to alveologenesis in
Porcnf/f; Dermo1Cre/+ lungs led to reduced PDGF signal transduction without affecting PDGF ligand
production or differentiation of alveolar type I and type II cells (Figure 3—figure supplement 7).
This suggests that loss of mesenchymal Wnt5a compromises PDGF signal reception but not ligand
production in fibroblasts/myofibroblasts. Conversely, loss of PDGF ligand resulted in depletion of
WNT5A-producing fibroblasts/myofibroblasts and a reduction in Wnt5a transcript levels (Figure 3—
figure supplement 8). These results support a positive feedback loop between WNT5A and PDGFA
to generate an adequate number of fibroblasts/myofibroblasts required for alveologenesis
(Figure 3N).
Components and regulators of the actomyosin cytoskeleton and
vesicular transport show differential expression in Vangl2 and Ror2
mutant lungs by RNA-Seq analysis
We performed bulk RNA-Seq analysis of control and Vangl2f/f; Sox9Cre/+ lungs collected at P2 and
P5. Our phenotypic analysis has revealed a major effect of epithelial PCP signaling on myofibroblasts
and perhaps other lung cell types as well. While it would be ideal to use sorted lung cells for RNA-
Seq, it would be difficult to sort myofibroblasts away from airway smooth muscle cells and vascular
smooth muscle cells since they express a similar set of markers. As expected, Pdgfra expression was
downregulated in Vangl2f/f; Sox9Cre/+ lungs while Pdgfa expression was not reduced. Several other
pathways that are perturbed were identified (Figure 4A and B, Figure 4—figure supplement 1).
They include actomyosin cytoskeleton signaling, Wnt/b-catenin signaling, LXR/RXR signaling, CXCR4
signaling, CDK5 signaling, Toll-like receptor signaling and acute phase response signaling.
We also performed RNA-Seq analysis on control and Ror2f/f; Sox9Cre/+ lungs collected at P2 and
P5 (Figure 4C and D). We expect that many changes in transcriptional responses would follow a sim-
ilar trend in lungs deficient in epithelial Vangl2 or Ror2, if Ror2 is responsible for mediating Vangl2
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Figure 4. Vangl2 and Ror2 regulate similar pathways. (A–D) Pathway analysis of transcriptomes derived from RNA-
Seq of control, Vangl2f/f; Sox9Cre/+, and Ror2f/f; Sox9Cre/+ lungs at postnatal (P) day 2 and 5 (n = 3 for each
group). The top 25 enriched terms in GO (gene ontology) biological processes were shown. Loss of Vangl2 or Ror2
revealed changes in similar pathways, suggesting that Vangl2 and Ror2 function in the same pathway. (E) Heatmap
of selected mouse genes from control and Vangl2f/f; Sox9Cre/+ lungs at P5. Loss of epithelial Vangl2 in mouse
lungs activated these genes. Interestingly, they are known to be elevated in lungs of human emphysema patients
and are biomarkers for emphysema.
The online version of this article includes the following figure supplement(s) for figure 4:
Figure supplement 1. Pathway analysis of differentially expressed genes identified in RNA-Seq analysis of control
and Vangl2f/f; Sox9Cre/+ lungs at postnatal (P) day 5.
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activity. Indeed, loss of Vangl2 and Ror2 showed similar changes in many pathways, affirming the
genetic studies in which they function in the same axis.
Vangl2-deficient interstitial fibroblasts/myofibroblasts have
disorganized actomyosin cytoskeletons and are defective in migration
assays
We found that myofibroblast proliferation was also diminished in Vangl2f/f; PdgfraCre/+ lungs but
only at later stages of postnatal development while the initial expansion of fibroblasts/myofibro-
blasts was unaffected (Figure 5A). This is in contrast to defective fibroblast/myofibroblast expansion
in Vangl2f/f; Sox9Cre/+ lungs (Figure 3C). These results suggest that the primary role of mesenchymal
PCP signaling is to control myofibroblast migration and function while epithelial PCP signaling plays
a key role in the initial expansion of fibroblasts/myofibroblasts. Both SMA and elastin production
was significantly reduced in Vangl2f/f; PdgfraCre/+ lungs (Figure 5B). It is expected that failure of
myofibroblast migration to the prospective site of secondary septation deprived them of receiving
the PDGF ligand for proliferation. It is interesting to note that myofibroblasts send out cellular exten-
sions to form a network of myofibroblasts after expansion of the fibroblast/myofibroblast population
(Figure 5—figure supplement 1). In this process, VANGL2 was found to colocalize with SMA on
these cellular extensions, suggesting a critical role of PCP signaling in controlling motility of myofi-
broblasts (Figure 5—figure supplement 1).
We examined the actomyosin cytoskeleton in Vangl2-deficient myofibroblasts from Vangl2f/f;
PdgfraCre/+ lungs in comparison with control myofibroblasts. Phalloidin staining of F-actin (filamen-
tous) revealed a disorganized actomyosin cytoskeleton and smooth muscle actin failed to produce
organized stress fibers in mutant myofibroblasts (Figure 5C). We also analyzed fibroblast/myofibro-
blast distribution in Vangl2f/f; PdgfraCre/+ lungs at P0 and P5 (Figure 5D). We found no difference in
the distribution of PDGFRA+ fibroblasts at P0. However, at P5 while PDGFRA+/SMA+ myofibroblasts
had migrated to the prospective sites of secondary septa in control lungs, PDGFRA+/SMA+ cells in
the mutant lungs stayed in the primary septa.
These results predict that migration of Vangl2-deficient myofibroblasts would be compromised.
To test this idea, we isolated myofibroblasts from control and Vangl2f/f; PdgfraCre/+ lungs and
seeded them onto the migration chamber. The rate of myofibroblast migration into the cell-free
area was measured. While control myofibroblasts occupied the cell-free area after 36–48 hr, only
scant Vangl2-deficient myofibroblasts were detected in the cell-free area during this time period
(Figure 5E and F). This indicates that the mobility of myofibroblasts was compromised due to loss
of PCP signaling in these cells. Reduced myofibroblast proliferation and migration thus underlies
defective alveolar development in Vangl2f/f; PdgfraCre/+ mice.
Alveolar type I cells devoid of VANGL2 are associated with disrupted
cytoskeletons and fail to encase myofibroblasts necessary for
secondary septa formation
Abnormal secondary septation in Vangl2f/f; Sox9Cre/+ lungs due to loss of epithelial Vangl2 suggests
that the primary defect originates from faulty alveolar epithelial cells. This is in contrast to the tradi-
tional view of secondary septa formation in which the main driving force of septa formation is
derived from myofibroblast migration and elastin deposition by myofibroblasts (Chao et al., 2016).
Having established a critical role of alveolar type I and type II cells in PDGF secretion during alveolo-
genesis, we assessed the function of Vangl2 in alveolar type I cells during alveolar formation. We
conjectured that abrogated PCP signaling in alveolar type I cells would perturb the actomyosin cyto-
skeleton and impair their ability to adopt the cell shape necessary for encasing myofibroblasts during
secondary septation. To validate this model, we initially used phalloidin to label F-actin and exam-
ined the actomyosin cytoskeleton in alveolar type I cells of control and Vangl2f/f; Sox9Cre/+ lungs.
Due to the extended morphology of alveolar type I cells, it was very difficult to obtain a clear view of
the actomyosin cytoskeleton. We then searched for other markers for the actomyosin cytoskeleton
and found that phosphorylated Cofilin and LIM-kinase (LIMK) were significantly increased in Vangl2-
deficient alveolar type I cells, compared to controls (Figure 6A, B and D). Phosphorylation of Cofilin
by LIMK inhibited its ability to depolymerize actin, leading to a failure in actin bundle remodeling
(Figure 6F). This would generate disorganized stress fibers in Vangl2-deficient AT1 cells.
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Figure 5. Vangl2 regulates the cytoskeleton of myofibroblasts and their migration. (A) Quantification of
myofibroblast proliferation in control and Vangl2f/f; PdgfraCre/+ lungs at postnatal (P) day 3 and 5. The rate of
myofibroblast proliferation was calculated as the ratio of the number of EdU+ myofibroblasts (EdU+PDGFRA+) to
the number of myofibroblasts (PDGFRA+). An apparent reduction in the percentage of proliferating myofibroblasts
Figure 5 continued on next page
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Disruption of the actomyosin cytoskeleton in alveolar type I cells in the absence of PCP signaling
raised the possibility that AT1 cells failed to undergo morphogenetic adjustment to sheathe myofi-
broblasts and capillaries during secondary septa formation. Indeed, immunohistochemical analysis
revealed slender Vangl2-deficient AT1 cells that failed to fold up to encase myofibroblasts
(Figure 6C and E). This observation was further validated by TEM studies of control and Vangl2f/f;
Sox9Cre/+ lungs. For instance, AT1 cells in control lungs at P3 displayed folding to sheathe myofibro-
blasts that had migrated to the prospective sites of secondary septa formation (Figure 1C). By con-
trast, such coordinated morphological changes in AT1 cells did not occur in the mutant lungs
(Figure 1C). These results imply an active role of AT1 cells in secondary septation likely through cell
shape change, which would complement the action of myofibroblast migration and contraction in
this highly coordinated process.
Taken together, we conclude that PCP signaling operates in both the lung epithelium and mesen-
chyme and control distinct aspects of cellular properties in each compartment necessary for alveolo-
genesis. This includes ligand secretion, cell shape change and migration.
Alveolar type I cells lacking VANGL1/2 are compromised in
alveolosphere formation
To further investigate the role of AT1 cells in alveolar formation, we adopted the alveolosphere
assay (Barkauskas et al., 2013) and examined the cellular behavior of control and Vangl1/2-deficient
alveolar cells in spheroid formation. This organoid system retains many important aspects of alveolar
formation and would reveal the intrinsic cellular defects in AT1 cells during alveologenesis
(Barkauskas et al., 2017). In this assay, fibroblasts/myofibroblasts are in direct contact with AT1 cells
and obviate the need of PDGF-mediated migration.
We isolated alveolar type II cells (GFP+) from SftpcCreER/+; ROSA26mTmG/+ mice (Lin et al., 2012;
Muzumdar et al., 2007) by fluorescence-activated cell sorting (FACS). Tamoxifen was injected into
SftpcCreER/+; ROSA26mTmG/+ mice to activate SftpcCreER and label SPC+ AT2 cells with GFP. Sorted
alveolar type II cells were mixed with fibroblasts and cultured in 3D. In this process, AT2 (SPC+) cells
proliferated and differentiated into AT1 (HOPX+) cells. After two weeks, lung organoids formed, in
which alveolus-like structures expressing markers for alveolar type I cells were produced from alveo-
lar type II cells in the presence of fibroblasts (Figure 6G and H). We performed a similar experiment
using Vangl1/2-deficient AT2 cells purified from Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+
mice that had been administered with tamoxifen to delete Vangl2 in SPC+ AT2 cells and in all AT1
cells originated from AT2 cells. In the absence of Vangl1/2, differentiation of AT2 cells and prolifera-
tion of AT2 and AT1 cells were unaffected. However, although a similar number of alveolospheres
Figure 5 continued
was detected in Vangl2f/f; PdgfraCre/+ lungs compared to controls (n = 3 for each group) at P5 but not at P3. (B)
qPCR analysis of Acta2 (SMA) and Elastin in control and Vangl2f/f; PdgfraCre/+ lungs at P5. The mRNA levels of
Acta2 and Elastin were significantly reduced in the absence of Vangl2 in myofibroblasts (n = 3 for each group). (C)
Immunostaining of lung sections collected from control and Vangl2f/f; PdgfraCre/+ mice at P5. The actomyosin
cytoskeleton (stained by phalloidin) failed to organize around the prospective sites of secondary septa formation
in Vangl2f/f; PdgfraCre/+ lungs. In addition, smooth muscle actin (SMA) levels were significantly reduced and did
not form stress fibers at the prospective sites of secondary septation. Arrows point to rudimentary secondary septa
in control lungs. (D) Immunostaining of lung sections collected from control and Vangl2f/f; PdgfraCre/+ mice at P0
and P5. Migration of myofibroblasts (PDGFRA+/SMA+) to the prospective sites of secondary septa failed to occur
in the mutant lungs. (E) Wound recovery assays to assess the migratory ability of myofibroblasts derived from
control and Vangl2f/f; PdgfraCre/+ lungs. Within 36–48 hr, the wound area has been populated by migrating
myofibroblasts derived from control lungs. By contrast, few myofibroblasts from Vangl2f/f; PdgfraCre/+ lungs
reached the wound area within the same time frame. (F) Quantification of wound recovery by myofibroblasts
derived from control and Vangl2f/f; PdgfraCre/+ lungs within 36–48 hr (n = 3 for each group). These results imply
that mesenchymal Vangl2 controls subsequent myofibroblast proliferation after the initial expansion or the
migration defect exerts a secondary effect on myofibroblast proliferation or both. All values are mean ± SEM. (***)
p<0.001 (unpaired Student’s t-test).
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. Myofibroblasts send out cellular extensions to form a network during alveologenesis.
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Figure 6. Vangl2 controls the cytoskeleton of alveolar type I cells, their cell shape changes and their ability in forming alveolospheres and new alveoli.
(A, B, D) Immunostaining of lung sections collected from Sox9Cre/+; ROSA26mTmG/+ (control) and Vangl2f/f; Sox9Cre/+; ROSA26mTmG/+ mice at postnatal
(P) day 3 and 5. GFP from the ROSA26 locus (ROSA26mTmG) was activated in both alveolar type I (AT1) and type II (AT2) cells which could be
distinguished by their morphology. The levels of phosphorylated (p) Cofilin and LIMK were significantly reduced in AT1 cells in control lungs by P5. By
Figure 6 continued on next page
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was obtained, the size distribution of the alveolospheres derived from Vangl1/2-deficient AT1 cells
was dominated by those with a smaller size (Figure 6G and H). In control spheres, HOPX+ AT1 cells
are located inside the spheres and are surrounded by SPC+ AT2 cells. This organization was not
observed in spheres, in particular, medium and small alveolospheres, derived from Vangl1/2-defi-
cient cells. This is consistent with defective cellular properties in Vangl1/2-deficient AT1 cells
required for morphogenesis.
To assess the role of AT1 cells in alveologenesis, we generated Vangl1gt/gt; Vangl2f/f; Aqp5CreER/+
mice and administered tamoxifen to these animals at P2. Activation of CreER by tamoxifen in Aqua-
porin 5 (AQP5)+ cells induced Vangl2 removal in AT1 cells. Analysis of lungs at P7 revealed areas of
defective alveolar development due to loss of Vangl1/2 (Figure 6I). This suggests a vital function of
Vangl1/2 in alveolar type I cells during alveologenesis. Together, our results support a central role of
Vangl1/2 in controlling the cellular behavior of AT1 cells during alveolar formation.
Loss of Vangl1/2 in alveolar type I cells impairs their ability to form
new alveoli following lung injury
To further assess the function of Vangl1/2 in AT1 cells during alveolar formation, we took advantage
of the observation that bleomycin applied to adult mouse lungs induces formation of new alveoli
(Walters and Kleeberger, 2008; Mouratis and Aidinis, 2011; Egger et al., 2013). In this setting, in
response to bleomycin-induced loss of alveoli and fibrosis, alveolar type II cells produce alveolar
type I cells, which contribute to new alveoli and lung repair in mice. This feature provided an ideal
setup for testing how loss of Vangl1/2 in AT1 cells affects their ability in alveolar formation. To this
end, we generated SftpcCreER/+; ROSA26mTmG/+ (control) and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+;
ROSA26mTmG/+ adult mice and injected them with tamoxifen to inactivate Vangl2 in alveolar type II
cells, which were also labeled by GFP (from the ROSA26mTmG locus). Alveolar type I cells produced
from alveolar type II cells would also be lineage-labeled by GFP. We then subjected these animals to
bleomycin following the standard protocol. After 4 weeks post-bleomycin administration, lung repair
was extensive in control lungs and newly formed alveoli had replaced the damaged lung tissues
(Figure 6J and K). By contrast, fewer GFP+ alveoli in Vangl1gt/gt; Vangl2f/f; SftpcCreER/+;
ROSA26mTmG/+ mice were found and they failed to reach the same size as that in control lungs
(Figure 6J and K, Figure 6—figure supplement 1). This suggests that Vangl1/2-deficient AT1 cells
were compromised in their ability to form new alveoli although Vangl1/2-deficient AT2 cells could
also contribute to the observed defects in alveolar repair. While additional studies are required,
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contrast, p-Cofilin and p-LIMK persisted in AT1 cells in Vangl2f/f; Sox9Cre/+; ROSA26mTmG/+ lungs. (C, E) Immunostaining of lung sections collected from
Sox9Cre/+; PdgfraH2BGFP/+ (control) and Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ mice at P3 and P5. Cell shape change of AT1 cells (T1a+) was observed in
control lungs at the prospective sites of secondary septation to encase myofibroblasts (H2BGFP+) (myo) that had migrated toward AT1 cells. AT1 cells
in Vangl2f/f; Sox9Cre/+; PdgfraH2BGFP/+ lungs failed to undergo similar morphological changes. (F) Schematic diagram of a Vangl2-initiated signaling
cascade that leads to phosphorylation of Cofilin and actin remodeling. (G) Immunostaining of alveolospheres derived from control and Vangl1gt/gt;
Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ mice injected with tamoxifen. Both SPC+ and HOPX+ cells were found in alveolospheres derived from control
and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ mice despite a difference in size and organization. (H) Quantification of the percentage of large
(cross-sectional area >0.06mm2), medium (cross-sectional area between 0.015mm2 and 0.06mm2) and small (cross-sectional area <0.015mm2)
alveolospheres derived from control and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ mice (n = 5 for each group). The percentage of large
alveolospheres derived from Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ mice was reduced. (I) Hematoxylin and eosin-stained lung sections of
wild-type and Vangl1gt/gt; Vangl2f/f; Aqp5CreER/+; ROSA26tdTomato/+ mice injected with tamoxifen and collected at P7. Enlarged saccules were found in
Vangl1gt/gt; Vangl2f/f; Aqp5CreER/+; ROSA26tdTomato/+ lungs with an increased MLI in comparison with controls (n = 3 for each group). (J) Immunostaining
of lung sections collected from SftpcCreER/+; ROSA26mTmG/+ (control) and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ mice injected with
tamoxifen and treated with bleomycin. Lungs were harvested at 30 days post-bleomycin administration. In control lungs, GFP-labeled AT2 cells
proliferated and differentiated into AT1 cells to form new alveoli. By contrast, fewer alveoli were produced in Vangl1gt/gt; Vangl2f/f; SftpcCreER/+;
ROSA26mTmG/+ lungs. (K) Quantification of the percentage of large (cross-sectional area >0.6mm2), medium (cross-sectional area between 0.2mm2 and
0.6mm2) and small (cross-sectional area <0.2mm2) alveoli derived from SftpcCreER/+; ROSA26mTmG/+ (control) and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+;
ROSA26mTmG/+ mice (n = 5 for each group). The percentage of large alveoli in Vangl1gt/gt; Vangl2f/f; SftpcCreER/+; ROSA26mTmG/+ lungs was reduced. All
values are mean ± SEM. (*) p<0.05; (**) p<0.01; (***) p<0.001; ns, not significant (unpaired Student’s t-test).
The online version of this article includes the following figure supplement(s) for figure 6:
Figure supplement 1. Bleomycin-induced lung injury results in a reduced MLI in the absence of Vangl1/2.
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these findings suggest a critical role of Vangl1/2 in controlling the cellular behavior of alveolar type I
(and/or type II) cells during alveolar formation.
COPD patients have reduced levels of WNT5A and VANGL2 expression
To explore whether studies of PCP signaling in alveolar formation in mice recapitulate human dis-
eases, we assessed PCP signaling in lung tissues of COPD/emphysema patients (Figure 7A and B).
We found that the expression levels of WNT5A and VANGL2 were reduced (Figure 7C), suggesting
a link between PCP signaling and alveolar loss/regeneration in these patients. This finding is consis-
tent with other studies in the literature, in which VANGL2 expression was reported to be downregu-
lated in a small cohort of COPD patient lungs (Poobalasingam et al., 2017). In addition,
polymorphisms of human VANGL2 have been associated with negative smoking impacts on lung
function in humans (Poobalasingam et al., 2017).
It is interesting to note that SERPINA3 (a protease inhibitor), SAA3 (serum amyloid A) and CD14,
whose expression was increased in Vangl2-deficient murine lungs (Figure 4E), are activated in
COPD patients and are biomarkers for COPD (Bozinovski et al., 2008; Wood et al., 2009;
von Scheele et al., 2011). This supports the idea that the PCP pathway is compromised in COPD
patients and may contribute to their inability to form new alveoli.
Taken together, our studies have provided new mechanistic insight into alveolar formation and
PCP signaling (Figure 7D). They also form the basis for future work to understand how different sig-
naling pathways are integrated during alveologenesis in development and following injury.
Discussion
Our studies have addressed a central question in alveolar development, the molecular basis of sec-
ondary septa formation (Figure 7D). Through genetic and molecular approaches, we decipher PCP
signaling through a Wnt5a–Ror2–Vangl2 axis as a key element in mediating cell-cell interactions
between alveolar cells (type I and type II) and myofibroblasts. The PCP pathway controls PDGF sig-
naling from alveolar type I and II cells to fibroblasts/myofibroblasts to promote their proliferation.
This essential step ensures the production an adequate number of fibroblasts/myofibroblasts
required for alveologenesis. A positive feedback loop between WNT5A and PDGF facilitates expan-
sion of fibroblasts/myofibroblasts. Subsequently, orchestrated movement between alveolar type I
cells and myofibroblasts is regulated by PCP signaling, including cell shape change of alveolar type I
cells and migration of myofibroblasts. As a result, they come in close proximity to each other and
undergo coordinated morphogenesis to produce secondary septa and alveoli. In this process, myofi-
broblasts also send out cellular processes to form a network that likely functionally connects alveoli.
These critical events require changes in cellular properties mediated by PCP signaling and reflect a
novel facet of PCP function. We speculate that this new insight can serve as a paradigm for under-
standing PCP function in other tissues beyond the classical tissue polarity. Moreover, our findings
suggest that the developmental programs executed by PCP are utilized for tissue repair in the lung.
This establishes the foundation for elucidating disease mechanisms of BPD and COPD caused by
alveolar loss.
Genetic and molecular analyses of Wnt5a, Ror2 and Vangl2-deficient lungs demonstrate a critical
role of these PCP components in controlling the actomyosin cytoskeleton, which underlies ligand
secretion/delivery, and cell migration and interaction during secondary septa formation. Surprisingly,
these processes do not appear to involve the classical tissue polarity, in which asymmetric distribu-
tion of PCP components is associated with polarization of cells (Ossipova et al., 2015). Instead, the
primary function of the Wnt5a–Ror2–Vangl2 axis is to modulate the cellular properties of lung cells
required for alveolar formation. Thus, while the PCP pathway functions in many cellular processes
that rely on the actomyosin cytoskeleton, our studies revealed that PCP activity is not confined to tis-
sue polarity. Our work shows that PCP signaling exerts its effects at the subcellular levels via control-
ling the cytoskeleton in alveolar type I, type II cells and myofibroblasts. This notion is consistent with
studies that reported a purported function of PCP in axonal guidance (Zou, 2012) or postsynaptic
compartmentalization (Nagaoka and Kishi, 2016), in which PCP was proposed to also operate at
the subcellular level. Moreover, our findings suggest that the PCP pathway controls important cellu-
lar processes beyond epithelial layers as demonstrated by the involvement of PCP signaling in myofi-
broblast migration. Hence, our investigation establishes novel modes of PCP function in tissue
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Figure 7. The WNT–VANGL axis is downregulated in the lungs of human emphysema patients. (A) Hematoxylin and eosin-stained lung sections of
normal and emphysema patients. Characteristic disruption of alveoli was observed in emphysema patients, resulting in increased airspace. (B) Elastin
staining of lung sections of normal and emphysema patients. The slides were counterstained with tartrazine. Elastin, which was detected at the
secondary septa in normal lungs (arrows), was greatly reduced in the lungs of emphysema patients. (C) qPCR analysis of VANGL1, VANGL2 and WNT5A
Figure 7 continued on next page
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patterning. We anticipate that additional cellular processes that utilize similar modes of PCP signal-
ing as reported here will be uncovered in other tissues.
Loss of Ror2 in either lung epithelium or mesenchyme recapitulates phenotypes due to lack of
Vangl2. This supports a crucial role of ROR2 in activating VANGL2 and downstream events. How-
ever, we cannot rule out the possibility that a Fz receptor (Wang et al., 2016) is also involved in
relaying the WNT5A signal to VANGL2. In this case, Fz and ROR2 would cooperate in a non-redun-
dant manner to transduce the WNT5A signal. Identifying the putative Fz receptor and elucidating its
functions would significantly increase our understanding of the signaling cascade that regulates sec-
ondary septa formation.
Our genetic and molecular studies support a new model in which morphological changes of AT1
cells induced by PCP signaling are required for secondary septa elongation. An active role of AT1
cells in secondary septation contrasts their passive role implied from the existing models in which
myofibroblasts drive secondary septa formation. Nevertheless, further studies are required to define
the functional consequence of PCP signaling in AT1 cells and delineate the relative contributions of
AT1 and AT2 cells to alveologenesis. We also showed that morphological changes in myofibroblasts
are also critical for secondary septa formation. Thus, secondary septa development relies on coordi-
nated cell shape changes in both alveolar epithelial cells and myofibroblasts. A key element in this
process is an altered actomyosin cytoskeleton controlled by the Wnt5a–Ror2–Vangl2 axis. How this
axis is integrated with other regulators of the cytoskeleton requires further investigations. We also
do not have the cellular resolution to discern the exact sequence of events. This would rely on
improved microscopy and the ability to image lung slices for an extended period of time. New cul-
ture conditions are also needed to recapitulate alveolar formation in ex vivo lung explants or lung sli-
ces. Future development of fluorescent probes that enable monitoring lung development in vivo
would be an important step forward to validate these models.
In this study, we have focused on AT1/2 cells and myofibroblasts in secondary septa formation. A
third component of the secondary septa is endothelial cells. It is unclear whether PCP signaling con-
trols capillary morphogenesis during alveolar development. This would require additional genetic
and molecular studies, similar to those described in this work. Interestingly, PCP signaling has been
implicated in network organization of vessels in other organs (Sewduth and Santoro, 2016).
Our analysis of Vangl2-deficient lungs revealed that PDGF ligands produced in alveolar cells fail
to signal to myofibroblasts. Our data point to defective delivery of the PDGF ligand due to dis-
rupted cytoskeleton in the absence of PCP signaling. Additional cell biological and biochemical stud-
ies are required to pinpoint the defects in PDGFA trafficking in alveolar type I and type II cells. We
propose that PDGF signal reception is compromised by loss of cell-cell contacts between alveolar
cells and mesenchymal myofibroblasts. Further validation of this model would require direct visuali-
zation of ligand–receptor interactions on juxtaposed membranes between ligand-producing and
–receiving cells, for instance, using split GFP technology (Feinberg et al., 2008) where GFP signal is
reconstituted at sites of ligand–receptor contact. An alternative possibility of cell-cell contacts
between alveolar cells and mesenchymal myofibroblasts involves actin-based filopodia. This is similar
to the cytonemes described in other systems including the mouse limb (Sanders et al., 2013). The
function of cytonemes has been debated but recent data show that they are required for mediating
ligand-receptor signaling for major signaling pathways in lieu of diffusion (Roy et al., 2014;
Huang and Kornberg, 2015). Cytonemes originate from ligand-producing and receptor-producing
cells, but cytonemes have not been reported in lung cells likely due to technical issues.
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in lungs from normal and emphysema patients (n = 12 for each group). The mRNA levels of VANGL2 and WNT5A were significantly reduced in
emphysema patients. All values are mean ± SEM. (*) p<0.05; (**) p<0.01; (***) p<0.001; ns, not significant (unpaired Student’s t-test). (D) A new model of
alveolar formation through control of cellular properties by PCP signaling. We propose that epithelial PCP signaling via the Wnt5a–Ror2–Vangl2 axis
(colored green) controls PDGF secretion from alveolar type I and type II cells to promote proliferation of mesenchymal fibroblasts. In this process, a
positive feedback loop between WNT5A and PDGF leads to expansion of the fibroblast pool required for subsequent alveologenesis. The expanded
fibroblast population expresses SMA and becomes myofibroblasts, which continue to proliferate. In addition, myofibroblasts migrate to the prospective
site of secondary septation in response to PCP signaling (colored blue). Likewise, epithelial PCP signaling (colored green) instructs cell shape changes
of alveolar type I cells necessary for encasing myofibroblasts that migrate toward the site of secondary septation. All of these cellular events (orange-
colored boxes) are due to modulation of the actomyosin cytoskeleton via the Wnt5a–Ror2–Vangl2 axis.
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In conclusion, our work has provided key new insights into the cellular and molecular basis of sec-
ondary septation and alveolar formation. Moreover, we have revealed a novel mode of PCP signal-
ing beyond tissue polarity. These studies set the stage for further investigation to obtain a complete
mechanistic understanding of alveolar development and repair.
Materials and methods
Animal husbandry
Mouse strains used in this study are listed in the Key Resources table (Supplementary file 1). Mat-
ings were set up to obtain mice with the indicated genotypes described in this study. This study was
performed in strict accordance with the recommendations in the Guide for the Care and Use of Lab-
oratory Animals of the National Institutes of Health. The Institutional Animal Care and Use Commit-
tee (IACUC) at the University of California, San Francisco, approved all experiments performed in
this study (protocol #AN173680-03).
Generation of Aqp5CreER mice
To produce the Aqp5CreER mouse line, the translational start ATG in the mouse Aqp5 genomic locus
was replaced with a CreER-FRT-PGK-Neo-FRT cassette though gene targeting in E14 embryonic (ES)
cells. The FRT-PGK-Neo-FRT cassette was subsequently removed by crosses with FLPe mice
(Rodrı´guez et al., 2000).
Histology and immunohistochemistry
Mouse lungs were dissected at the indicated time points and fixed in 4% paraformaldehyde (PFA) in
PBS on ice for 1 hr. Tissues were embedded in paraffin wax or OCT (frozen sections) and sectioned
at 7 mm. Thick sections were prepared in a similar manner. Histological analysis, such as hematoxylin
and eosin (H&E) staining, was performed as described (Lin et al., 2017).
Elastin fiber staining was performed following Hart’s staining method with minor modifications.
Lung sections were deparaffinized with xylene, rehydrated with ethanol and water, and then placed
in the working solution (10% Weigert’s iron resorcin-fuchsin stock solution, 2% HCl and 70% ethanol)
overnight at room temperature. After three washes in water, the sections were counterstained in
0.5% tartrazine/0.5% acetic acid for 3 min. Sections were rinsed three times in water and dehydrated
with ethanol and xylene. The elastin fibers were stained black.
Immunohistochemistry was performed following standard procedures (Lin et al., 2017). Antibod-
ies used in this study are listed in the Key Resources table (Supplementary file 1). The following pri-
mary antibodies were used for paraffin wax sections: rabbit anti-NKX2.1 (1:100, Epitomics), chicken
anti-GFP (1:200, abcam), goat anti-CC10 (1:200, Santa Cruz Biotechnology), rabbit anti-prosurfactant
protein C (proSP-C) (1:200, MilliporeSigma), hamster anti-T1a (1:200, Developmental Studies
Hybridoma Bank), mouse anti-HOPX (1:100, Santa Cruz Biotechnology), and rabbit anti-phospho-
AKT (Ser473) (1:150, Cell Signaling Technology). The following primary antibodies were used for fro-
zen sections: rat anti-E-cadherin (1:200, Invitrogen), chicken anti-GFP (1:300, abcam), mouse anti-
ACTA2 (1:200, Thermo Scientific Lab Vision), rat anti-PECAM-1 (CD31) (1:150, Santa Cruz Biotech-
nology), rabbit anti-PDGFRA (1:150, Cell Signaling Technology), rabbit anti-phospho-PDGFRA
(Tyr754) (1:100, Cell Signaling Technology), rabbit anti-Cofilin (1:150, Cell Signaling Technology),
rabbit anti-phospho-Cofilin (Ser3) (1:100, Cell Signaling Technology), rabbit anti-phospho-LIMK1
(Thr508)/LIMK2 (Thr505) (1:100, Cell Signaling Technology), and rat anti-VANGL2 (1:150, Millipore-
Sigma). Secondary antibodies and conjugates used were donkey anti-rabbit Alexa Fluor 488 or 594
(1:1000, Life Technologies), donkey anti-goat Alexa Fluor 488, donkey anti-chicken Alexa Fluor 488
or 647 (1:1000, Life Technologies), donkey anti-mouse Alexa Fluor 488 or 594 (1:1000, Life Technolo-
gies), and donkey anti-rat Alexa Fluor 594 (1:1000, Life Technologies). For biotinylated secondary
antibodies, goat anti-hamster (1:1000, Jackson ImmunoResearch Laboratories), donkey anti-rabbit
(1:1000, Jackson ImmunoResearch Laboratories), donkey anti-rat (1:1000, Jackson ImmunoResearch
Laboratories) and horse anti-mouse (1:1000, Jackson ImmunoResearch Laboratories) were used. The
signal was detected using streptavidin-conjugated Alexa Fluor 488, 594, or 647 (1:1000, Life Tech-
nologies). For antibodies against PDGFRA, phospho-PDGFRA (Tyr754), phospho-Cofilin (Ser3), phos-
pho-AKT, phospho-LIMK1 (Thr508)/LIMK2 (Thr505) and VANGL2, instead of using streptavidin-
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conjugated Alexa Fluor 488, 594, or 647 as the tertiary antibody, HRP-conjugated streptavidin
(1:1000, Perkin-Elmer) was used in combination with fluorogenic substrate Alexa Fluor 594 tyramide
for 30 s (1:200, TSA kit; Perkin Elmer). F-actin was stained with rhodamine-conjugated phalloidin
(1:200; Sigma).
For determining VANGL2 localization and distribution in the lung, frozen sections (at 20 and 50
mm) were prepared from the lungs of Sox9Cre/+; ROSA26mTmG/+ and PdgfraCreER/+; ROSA26mTmG/+
mice. Sections were incubated with chicken anti-GFP and rat anti-VANGL2 at 4˚C overnight. Donkey
anti-chicken Alexa Fluor 488 and biotinylated donkey anti-rat secondary antibodies were incubated
at 4˚C overnight. Streptavidin-conjugated HRP tertiary antibody was incubated at room temperature
for 2 hr to detect the VANGL2 signal.
For visualizing PDGFA localization and distribution in the lung, lungs from Pdgfaex4COIN/+; Sox2-
Cre/+ mice at P2 were collected and fixed in 4% PFA on ice for 1 hr. Lungs were washed in 0.02%
NP40 in PBS for 2 hr, and placed in X-gal staining solution (5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, 1 mg/ml X-gal) for 16 hr at
37˚C. LacZ-stained lungs were paraffin embedded and sectioned. Immunohistochemistry was subse-
quently performed on LacZ-stained sections using antibodies against HOPX (AT1 cell marker) and
SPC (AT2 cell marker).
Images for H&E staining, elastin staining and LacZ staining were taken using a SPOT 2.3 CCD
camera connected to a Nikon Eclipse E1000 microscope. Confocal images were captured on a Leica
SPE laser-scanning confocal microscope. Adjustment of red/green/blue/grey histograms and channel
merges were performed using LAS AF Lite (Leica Microsystems).
Transmission electron microscopy (TEM)
Lungs from Vangl2f/f; Sox9Cre/+ mice and their littermate controls were infused with EM fixative (2%
glutaraldehyde and 4% paraformaldehyde in PBS) through the trachea. Dissected lungs were
immersed in ice-cold EM fixative for at least 2 hr. The samples were trimmed to 1 mm cubes and
sectioned at 0.1 mm. The ultrathin sections were placed on copper grids and post-stained. Grids
were viewed and photographed with a JEOL JEM-1400 Transmission Electron Microscope at the
Cell Sciences Imaging Facility at Stanford University.
Measurement of the mean linear intercept (MLI)
The mean linear intercept (MLI) (Lm) was measured according to the previously reported methods
(Nagendran et al., 2018) with minor modification. In brief, for each animal 15 fields of hematoxylin
and eosin-stained lung sections from three different slides were imaged at 20x magnification using a
Nikon Eclipse E1000 Microscope. Fields that contained visible blood vessels or airways were
excluded. A grid with 10 horizontal and 10 vertical lines was superimposed on the images using
ImageJ. The number of times that the alveolar walls (the primary and secondary septa) intercepted
the grid lines was counted. Lm was calculated using the following equation: Lm = (Lh + Lv)/m, where
Lh is the total length of horizontal line, Lv is the total length of vertical line, and m is the total num-
ber of intercepts.
Cell proliferation assays
The rate of cell proliferation was determined through a short pulse of EdU labeling (Lin et al.,
2017). Briefly, mouse pups at postnatal day 0, 2, 5 and 7 were intraperitoneally injected with 0.25
mg of EdU (50 ml of EdU/PBS solution at 5 mg/ml) and lungs were collected 1 hr following EdU injec-
tion. Assessment of EdU incorporation was performed on paraffin-embedded lung sections using
the Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies). These lung sections were co-
stained with antibodies against NKX2.1 or GFP.
For quantifying proliferation of alveolar fibroblasts and myofibroblasts, proliferating cells were
labeled by EdU while fibroblasts/myofibroblasts were distinguished by H2BGFP expressed from the
Pdgfra locus (the PdgfraH2BGFP allele). The proliferation rate of alveolar fibroblasts/myofibroblasts
was calculated as the ratio of (EdU+H2BGFP+ cells)/(H2BGFP+ cells).
Alternatively, alveolar fibroblasts and myofibroblasts were identified by anti-PDGFRA antibodies.
In this case, the proliferation rate of alveolar fibroblasts/myofibroblasts was calculated as the ratio of
(EdU+PDGFRA+ cells)/(PDGFRA+ cells).
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Proximity Ligation In Situ Hybridization (PLISH)
In situ hybridization was performed following the procedure of Proximity Ligation In Situ Hybridiza-
tion (PLISH) (Nagendran et al., 2018) with minor modifications. Lungs from PdgfraH2BGFP/+ mice
were dissected and fixed in 4% paraformaldehyde overnight and embedded in OCT for frozen sec-
tions at 16 mm. Lung sections were incubated with H probe pairs, which were targeted to the adja-
cent positions in a tiled manner along the mRNA of interest. Nine H probe pairs for mouse Wnt5a
and ten H probe pairs for mouse Ror2 were used (see Supplementary file 2). In the circularization
reaction, the barcode sequences in the paired probes hybridized to the ’bridge’ (phosphorylated
VB02) and ’circle’ (phosphorylated CCC2.1) oligonucleotides to form a closed circle, which under-
went rolling circle replication to generate a long single-stranded amplicon of tandem repeats. Fluo-
rescently-labeled oligonucleotides were hybridized to the complementary tandem repeats and
generated bright puncta for visualization.
For combined in situ hybridization/immunohistochemistry, samples were washed 3 times in PBST
(0.05% Tween-20 and 5 mM EDTA in PBS) after PLISH and incubated in blocking buffer (3% BSA,
0.1% Triton X-100 and 5 mM EDTA in PBS) for 30 min. The sections were then incubated with pri-
mary antibodies (goat anti-CC10 or chicken anti-GFP in blocking buffer) for 2 hr at room tempera-
ture, washed in PBST and then incubated with secondary antibodies (donkey anti-goat Alexa Fluor
488 or donkey anti-chicken Alexa Fluor 488) for 1 hr at room temperature.
Lentivirus production and transduction
cDNAs encoding PDGFA-3xFLAG and PDGFA-eGFP fusions were cloned into the modified pSECC
lentiviral vector. The mouse PDGFA (NM_008808.4) coding sequence was amplified from mouse P3
lung cDNA library.
Lentiviruses were produced in HEK293T cells grown in DMEM containing 10% FBS, 1x penicillin/
streptomycin and 1x L-glutamine. One day before transfection, HEK293T cells were seeded at 50–
60% confluence in a 6 cm dish; cells reached 80–90% confluence for transfection the following day.
For HEK293T cells on one 6 cm dish, 1 mg of pMD2.G, 1 mg of psPAX2 and 2 mg of the plasmid of
interest (PDGFA-3xFLAG or PDGFA-eGFP) were mixed in 500 ml OPTI-MEM and 30 ml of polyethyle-
nimine (PEI) (1 mg/ml, transfection reagent) was added. Media were replaced 24 hr post-transfection
and viral supernatants were harvested 48 hr post-transfection. The viral supernatants were filtered
through 0.45 mm PVDF filters and then added to control and Vangl1gt/gt; Vangl2–/– adherent mouse
cells together with 8 mg/ml polybrene. 12 hr after transduction, the media were replaced with regu-
lar culture media (DMEM with 10% FBS and 1% penicillin/streptomycin).
PDGFA secretion assay
Control and Vangl1gt/gt; Vangl2–/– cells were derived from mouse embryos at 13.5 and 18.5 dpc,
authenticated by methods such as PCR and STR profiling, and tested negative for mycoplasma con-
tamination. Loss of Vangl1/2 ensures a complete removal of signaling through VANGL1/2, These cell
lines were lentivirally transduced with constructs that expressed 3xFLAG-tagged PDGFA as
described above. Cells were seeded onto 6 cm dishes. Once cells reached 100% confluence, the
media were replaced with OPTI-MEM supplemented with insulin, transferrin and selenium (ITS) and
cells were cultured for another 16 hr. The supernatants were then collected and filtered through
0.45 mm filters. Protein inhibitor cocktails were added to the filtrates, which were centrifuged at high
speed (>12000 rpm) for 15 min at 4˚ to remove cell debris and protein aggregates. The filtrates
were further concentrated in protein concentration columns (Millipore CENTRICON YM-10 Centrifu-
gal Filter Unit 2 mL 10 kDa) through centrifugation at 2000 g for 1 hr at 4˚C. In parallel, cells on the 6
cm dishes were scraped for lysis. Immunoprecipitation (IP) buffer (50 mM Tris pH 7.4, 2 mM EDTA,
150 mM NaCl, 0.5% Triton X-100, 1x protein inhibitor cocktail) was added to the concentrated fil-
trates or scraped cells in a total volume of 500 ml. Immunoprecipitation was performed using FLAG-
M2 beads following standard procedures. SDS-PAGE sample buffer was added to the immunopreci-
pitates for western blot analysis. PDGFA secretion was calculated using the following equation:
Psecretion = Ps/(Ps + Pc) where Ps = PDGFA in supernatant/medium, Pc = PDGFA in the cell lysate.
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Alveolosphere assays
Alveolosphere assays were performed as previously described (Barkauskas et al., 2013) with minor
modifications. Briefly, SftpcCreER/+; ROSA26mTmG/+ and Vangl1gt/gt; Vangl2f/f; SftpcCreER/+;
ROSA26mTmG/+ mice were injected with tamoxifen to label alveolar type II (AT2) cells with eGFP.
One month post-tamoxifen injection, lungs were dissected and digested in dispase (1.2 U/ml), colla-
genase B (0.5 mg/ml) together with 50 U/ml DNase at 37˚C. After incubation for 1 hr, an equal vol-
ume of sorting media (phenol red free DMEM with 2% FBS and 2% penicillin/streptomycin) was
added to the dissociated cells. The mixture was then passed through 70 mm cell strainers and centri-
fuged at 600 g for 10 min. Cell pellets were resuspended in 3 ml RBC lysis buffer (Invitrogen) for 2
min on ice and 5 ml sorting medium was added. The mixture was passed through the 40 mm cell
strainer. After centrifugation at 600 g for 10 min, cell pellets were resuspended in 1 ml sorting buffer
for fluorescence-activated cell sorting (FACS). eGFP-labeled AT2 cells were isolated using a BD FAC-
SAria III sorter. 5  103 sorted AT2 cells and 5  104 Mlg 2908 cells (ATCC CCL-206, a lung fibro-
blast cell line) were added to 100 ml culture medium (DMEM/F12 supplemented with Glutamax, 10%
FBS, 1x insulin/transferrin/selenium, 2x penicillin/streptomycin, 0.25 mg/ml Amphotericin B, 0.04 mg/
ml EGF, 0.05 mg/ml bFGF, 0.02 mg/ml KGF, and 0.02 mg/ml HGF), mixed with an equal volume of
Matrigel (BD Biosciences), and then seeded into a 0.4 mm Transwell insert (Corning) in a 24-well
plate. The medium was replaced every two days. After three weeks of culture, the Transwell inserts
were fixed in 4% paraformaldehyde at 4˚C overnight and embedded in OCT. The organoid/Matri-
gel-containing inserts were sectioned at 50 mm for immunohistochemistry.
RNA-Seq analysis
RNA-Seq was performed as previously described (Lin et al., 2017). In brief, the left lung lobe from
control, Vangl2f/f; Sox9Cre/+ and Ror2f/f; Sox9Cre/+ mice were homogenized in 1 ml TRIzol (Life Tech-
nologies) and 200 ml chloroform was then added. After centrifugation, the upper aqueous layer was
removed and mixed with an equal volume of 70% ethanol. RNA was extracted with the RNeasy Mini
Kit (Qiagen) following the manufacturer’s instructions. RNA quality was evaluated using the Agilent
2100 Bioanalyzer. Samples were sequenced on an Illumina HiSeq 2000 or HiSeq4000. Functional
enrichment analysis was performed using Ingenuity Pathway Analysis software (version 7.1). Differen-
tial gene expression and gene ontology (GO) enrichment analyses were performed with RStudio.
The barplot of gene ontology enrichment was created in order to visualize differentially expressed
genes that are associated with a certain biological process (BP). Datasets have been deposited in
NCBI’s Gene Expression Omnibus database and are accessible through GEO Series accession num-
ber GSE140779.
qPCR analysis
RNAs extracted from lung tissues were reverse-transcribed with the Maxima First Strand cDNA Syn-
thesis Kit (Thermo Scientific). Quantitative PCR (qPCR) was carried out on the ABI Prism 7900HT
Sequence Detection System. Primers for qPCR are listed in the Sequence-based reagent table.
Cell migration (wound recovery or healing) assay
The migratory capacity of lung myofibroblasts was determined using the Culture-Insert 2 Well sys-
tem (ibidi). Briefly, lungs from control and Vangl2f/f; PdgfraCre/+ mice at P3 were dissected and
digested in dispase (1.2 U/ml) and collagenase B (0.5 mg/ml) at 37˚C to release single cells. After
incubation for 1 hr, an equal volume of culture medium (DMEM with 10% FBS and 2% penicillin/
streptomycin) was added to dissociated cells. The mixture was then passed through a 40 mm cell
strainer and centrifuged at 600 g for 10 min. Cell pellets were resuspended in 200 ml culture medium
and seeded into wells (100 ml per well). Myofibroblasts were allowed to attach to fibronectin–coated
plates for 2–3 hr. Non-adherent cells were washed out and myofibroblasts were cultured to reach
100% confluence in ~2–3 days. Confluent myofibroblasts were switched to starvation medium
(DMEM with 0.2% FBS and 1% penicillin/streptomycin) for 16 hr prior to removal of the insert. Migra-
tion of myofibroblasts into the wounded area (insert) was allowed to continue for another 36–48 hr.
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Human lung tissues
Lung samples were obtained at the time of lung transplantation performed for severe emphysema
(Global Initiative for Chronic Obstructive Lung Disease Criteria, stages III or IV) during the study
period 2015-2019. Control lung tissues were obtained from donor lungs not utilized for lung trans-
plantation. Our studies indicate that these lungs are physiologically and pathologically normal
(Ware et al., 2002). Written informed consent was obtained from all subjects and the study was
approved by the University of California, San Francisco Institutional Review Board (IRB approval #
13–10738).
Statistical analysis
Both technical replicates and biological replicates (using different cell lines and mice) were per-
formed. All results were presented as mean ± SEM. Two-tailed Student’s t-tests were used to calcu-
late the P values. Statistical significance was considered only when the P value was less than 0.05.
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